Skip header and navigation

Refine By

22 records – page 1 of 3.

Pertussis Antigen vials

https://mhc.andornot.com/en/permalink/artifact8768
Dates
1938
circa 1938
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectiious Diseases
Vaccination
Accession Number
1997.2.7
Description
A cardboard box wrapped around with printed labels describing contents and usage; contains vials of pertussis (whooping cough) antigen; unopened.
  1 image  
Accession Number
1997.2.7
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectiious Diseases
Vaccination
MeSH Heading
Drugs
Antigens
Pertussis Vaccine
Vaccination
Immunization
Whooping Cough -- drug therapy
MM= Drug Packaging -- container -- vial
Description
A cardboard box wrapped around with printed labels describing contents and usage; contains vials of pertussis (whooping cough) antigen; unopened.
Number Of Parts
1
Provenance
Acquired from the Academy of Medicine; source: Dr. H.B. Rundle (1911-1997) via Mr. Howard Rundle.
Maker
Lederle Laboratories Inc.
Site Made (City)
New York
Site Made (State)
New York
Site Made (Country)
United States of America
Dates
1938
circa 1938
Material
cardboard
paper: off-white
ink: black
glass
liquid
Inscriptions
Printed on box: "3 vials 2 cc. size // PERTUSSIS ANTIGEN // (DETOXIFIED) // Lederle (in cursive script) // BACTERIAL ANTIGEN MADE FROM // Pertussis Bacillus"
Permanent Location
Storage Room 0010
0010-A2-4 Row F
Temporary Location
On display: "Vaccines and Immunization: Epidemics, Prevention, and Canadian Innovation"; Museum of Health Care, Nov. 28, 2013.
Dimension Notes
Length 5.7 cm x Width 4.0 cm x Depth 2.4 cm
Condition Remarks
Label intact; stained and discoloured.
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #UHN
Images
Less detail

glycerated vaccine virus

https://mhc.andornot.com/en/permalink/artifact14730
Dates
1935
1939
circa 1935-1939
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
Accession Number
1997.3.2 a-b
Description
Empty rectangular cream cardboard box.
Accession Number
1997.3.2 a-b
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
MeSH Heading
Vaccination
Smallpox Virus
Immunization
Public Health
Description
Empty rectangular cream cardboard box.
Number Of Parts
1
Provenance
Acquired from the Academy of Medicine; source: Penny Ecclestone; belonged to her father, Dr. Leland W. C. Sturgeon (1905-78).
Maker
Connaught Laboratories
Site Made (City)
Toronto
Site Made (State)
Ontario
Site Made (Country)
Canada
Dates
1935
1939
circa 1935-1939
Material
cardboard: cream
ink: black, red
Inscriptions
On box: “2 TUBES // VACCINE VIRUS, GLYCERINATED // Canadian // Licence // No. 3 // Connaught Laboratories, University of Toronto // NOT TO BE SOLD // Distributed FREE by the Department of Health, Ontario //KEEP IN REFRIGERATOR // If kept in a temperature below 5’C (41’F), this vaccine will retains its // potency until AUG 27 1939 Lot 380-2”
Permanent Location
Storage Room 0010
0010-A3-4 Row A Box 2
Length
9.0 cm
Width
1.2 cm
Depth
1.2 cm
Unit Of Measure
centimeters
Copy Type
original
Research Facts
Dr. Sturgeon graduated from the University of Toronto Faculty of Medicine in 1930; he was in private practice from 1931 to 1940, at which time he joined the RCAF as a medical officer; in 1945, he went into Public Health in Welland, Ont., where he was Medical Officer of Health until his retirement in 1973.
Less detail
Dates
1910
circa 1910
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
Accession Number
000001082
Description
Cylindrical wooden container with lid, wrapped with a paper label around circumference; overlaid with another, smaller paper label; contains a tube of rolled paper that surrounds nine sealed (glass?) tubes of liquid.
  2 images  
Accession Number
000001082
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
MeSH Heading
Vaccines
Vaccination -- instrumentation
MM= Drugs -- vaccines -- container
Description
Cylindrical wooden container with lid, wrapped with a paper label around circumference; overlaid with another, smaller paper label; contains a tube of rolled paper that surrounds nine sealed (glass?) tubes of liquid.
Number Of Parts
1
Provenance
Collected by Parke-Davis
Maker
Parke, Davis
Dates
1910
circa 1910
Date Remarks
Label gives Sept. 9, 1910 as a "best before" date.
Material
glass: amber
paper: red; yellow; black
wood: light brown
Inscriptions
"TEN TUBES // VACCINE (GLYCERINATED) // WITH SCARIFYING NEEDLE // PHYSIOLOGICALLY AND BACTERIOLOGICALLY TESTED // CAUTION--Keep the package below [illeg.] 0°F. if possible; summer tem- // perature will rapidly weaken vaccine. // We would recommend that this product be returned after SEPT - 9 - 1910 [stamped] // to be replaced with fresh product. This vaccine will, however, retain its potency for // a much longer period, if kept under proper conditions. // Note directions enclosed before using the vaccine. // LICENSE No. 1, issued to Parke, Davis by the Secretary of the Treasury, // U.S.A., under provision of Act approved July 1, 1902. // 014472 - P // PREPARED IN THE BIOLOGICAL LABORATORIES OF // PARKE, DAVIS & CO. DETROIT, MICH. U.S.A. // [illeg.] N LABORATOR [illeg.] WALKERVILLE, Ontario. // [illeg.] AL. Quebec. [illeg.] NOON, England."
Permanent Location
Storage Room 0010
0010-A
Temporary Location
On exhibit at City of Ottawa - Public Health L-2016-3 14 Mar 2016 – 31 Dec 2018
Dimension Notes
Length 9.7 cm x Diam. 1.4 cm
Condition Remarks
Wooden container is in good shape; labels and yellowed, torn, abraded, and wrinkled and are missing pieces
Copy Type
Original
Exhibit History
On exhibit, "Potions, Pills, and Prescriptions," Museum of Health Care, May 1, 2000.
Images
Less detail

measles vaccine kit

https://mhc.andornot.com/en/permalink/artifact4044
Dates
1968
circa 1968
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001249 a-g
Description
A styrofoam container (a) consisting of two moulded pieces of styrofoam held together by the label; inside are five cylindrical glass ampoules (b-f) with icicle-shaped melted glass seals containing the vaccine and one glass vial (g) stopped with a rubber stopper and sealed with a metal ring around …
  4 images  
Accession Number
000001249 a-g
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Measles -- prevention & control
Measles Vaccine
Vaccination
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- ampoule
Description
A styrofoam container (a) consisting of two moulded pieces of styrofoam held together by the label; inside are five cylindrical glass ampoules (b-f) with icicle-shaped melted glass seals containing the vaccine and one glass vial (g) stopped with a rubber stopper and sealed with a metal ring around the lip containing a diluent.
Number Of Parts
7
Part Names
a - box - Size: Length 13.9 cm x Width 8.3 cm x Depth 3.0 cm
b - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
c - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
d - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
e - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
f - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
g - vial - Size: Length 4.1 cm x Diam. 2.1 cm
Provenance
Collected by Parke-Davis
Maker
Philips Roxane, Inc.
Site Made (City)
St. Joseph
Site Made (State)
Missouri
Site Made (Country)
United States of America
Dates
1968
circa 1968
Date Remarks
Earliest expiry date
Material
styrofoam: white
paper: white; blue; black
glass: clear; blue
rubber: yellow
metal: silver
Inscriptions
(a) Top: "5 DOSES Bio. 49 // MEASLES VIRUS VACCINE, // LIVE, ATTENUATED // C // Contains 5 one-dose ampoules of attenuated Edmonston strain vaccine grown on // tissue cultures of canine renal cells and one 4.5 cc. vial of diluent for preparing solu- // tion for injection. Diluent contains 0.05% methylparaben and 0.005% propylparaben // as preservatives. // Prepare solution for injection by slowly adding 0.7 cc. diluent to contents of // ampoule. Gently agitate and allow a few seconds for the contents to dissolve. // DOSE – A single injection of 0.5 cc. of solution prepared as above, administered // subcutaneously into the upper arm; or subcutaneously or intramuscularly into the // upper, outer quadrant of the buttocks. For coadministration of gamma globulin, // see package insert. // Administration to infants under nine months of age is not recommended. // See package insert for contraindications and precautions. // Expiration Date: [printed] // Oct. 15, 1969 [stamped] // Lot No. [printed] // PD804B [stamped] // Stock 4-49-1-70 // Distributed by // PARKE, DAVIS & CO. DETROIT, MICH., U.S.A."; front: "Each dose contains not less than 1000 TCid50 ["50" subscr.] of measles virus vaccine as compared // to U.S. NIH measles virus reference standard, not more than 33 mcg. dihydrostrep- // tomycin sulfate and 17 units of polymyxin B sulfate. // CUT ON DOTTED LINE // Store at temperature between 2° and 8° C (35.6° and 46.4° F.). // Storage at freezing temperature not required. // Protect vaccine from prolonged exposure to direct sunlight."; back: "Manufactured by // PHILIPS ROXANE, INC. ST JOSEPH, MO., U.S.A. // U.S. Licence 376. Canadian Licence 127"; (b-e) "1 DOSE Bio. 49 // MEASLES VIRUS VACCINE, // LIVE, ATTENUATED // 1000 TCID50 ["50" subscr.] // See insert. // US. Licence 376 // Mfd. by Philips Roxane, Inc. // St. Joseph, Mo., U.S.A. // Dist. by Parke, Davis & Co. // Detroit, Mich., U.S.A.// LOT PD 804B // Exp. )ct. 15-69 [stamped]"; (f) same printed text as (b-e) followed by "LOT PD619-1 // Exp. Aug. 24-68"; (g) "4.5 CC. // DILUENT FOR MEASLES VIRUS // VACCINE, LIVE, ATTENUATED // Mfd. by Philips Roxane, Inc. // St. Joseph, Mo., U.S.A. // Dist. by Parke, Davis & Co. // Detroit, Mich., U.S.A. // Contains 0.05% methylparaben and // 0.005% propylpara- // ben as preservatives. // LOT 7404D [stamped]"
Permanent Location
Storage Room 0010
0010-A3-5 Row B
Temporary Location
On exhibit at City of Ottawa - Public Health L-2016-3 14 Mar 2016 – 31 Dec 2018
Condition Remarks
Label is yellowing, dirty; some dents in styrofoam; labels on ampoules and vial are yellowing.
Copy Type
Original
Exhibit History
May 24 - Sept. 13, 2001: Agnes Etherington Art Centre Museopathy exhibit
Images
Less detail

animal vaccine injector kit

https://mhc.andornot.com/en/permalink/artifact4068
Dates
1931
circa 1931
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
Accession Number
000001275 a-g
Description
Kit consists of (a) a cardboard box and (b) its lid, (c) the injector syringe: a metal barrel with a needle tip; inside the barrel is a spring-loaded plunger to push the pellet through the needle; spring is coiled and sprung by means of a metal knob on the side of the barrel that moves through a ho…
  1 image  
Accession Number
000001275 a-g
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
MeSH Heading
Vaccines
Veterinary Drugs
Syringes
Injections -- instrumentation
Vaccination
MM= Drugs -- vaccines -- container
MM= Injections -- accessories
MM= Drug Packaging -- container -- vial
Description
Kit consists of (a) a cardboard box and (b) its lid, (c) the injector syringe: a metal barrel with a needle tip; inside the barrel is a spring-loaded plunger to push the pellet through the needle; spring is coiled and sprung by means of a metal knob on the side of the barrel that moves through a hole cut in the barrel for that purpose; (d) a metal tube that serves as a cap for the needle, (e) a cylindrical plastic vial, stopped with a cork and wrapped in a paper label with one pellet inside, (f) a paper notice, and (g) an instruction leaflet; box is lined with crumpled tissue paper that has not been given an accession number.
Number Of Parts
7
Part Names
a - box bottom - Size: Length 18.0 cm x Width 3.4 cm x Depth 3.3 cm
b - box lid - Size: Length 18.3 cm x Width 3.8 cm x Depth 3.4 cm
c - syringe - Size: Length 14.8 cm x Diam. 2.1 cm
d - cap - Size: Length 4.1 cm x Diam. 0.6 cm
e - vial - Size: Length 2.2 cm x Diam. 0.6 cm
f - notice - Size: Length 7.7 cm x Width 4.1 cm
g - leaflet (unfolded) - Size: Length 17.3 cm x Width 10.6 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co., Ltd.
Site Made (City)
Walkerville
Site Made (State)
Ontario
Site Made (Country)
Canada
Dates
1931
circa 1931
Date Remarks
Based on lot number
Material
cork: brown
paper: white; beige; black; blue
metal: silver
cardboard: brown; grey
plastic: translucent yellow
Inscriptions
(a) Bottom: "MADE IN U.S.A. [stamped]"; (b) left side: "Animal Vaccine // INJECTOR // Syringe No. 17 // C779206 [stamped] // PARKE DAVIS & CO [engraved]"; (e) "BLACKLEG VACCINE // SINGLE Dose: 1 Oid. // Use // before June 1935 // C691502 // PARKE, DAVIS & Co."; (f) "NOTICE // When the syringe was packed it was examined and // found to be in perfect order, and should reach you // in that condition. We cannot, therefore, hold our- // selves resposible for any injury which may occur // to the instrument after its receipt. We do not // accept any syringe for credit or exchange after it // has been used. // PARKE, DAVIS & CO., Ltd."; (g) "How to Use the Animal // Vaccine Injector // [text follows] // TO PREVENT THE SPREAD OF INFECTION // [text follws] // PARKE, DAVIS & CO., LTD. // WALKERVILLE, ONTARIO"
Permanent Location
Storage Room 0010
0010-A3-4 Row D
Condition Remarks
Water mark on box bottom and bottom edge of box top; corners of box top scuffed, dented; no corrosion on syringe or cap; paper label on vial yellowing; vial lip broken, with a piece missing; cork still fits securely; paper leaflets are yellowed
Copy Type
Original
Reference Types
Document
Reference Comments
Parke-Davis Lot Numbering System
Images
Less detail
Dates
1975
circa 1975
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001281 a-c
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
  1 image  
Accession Number
000001281 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1975
circa 1975
Date Remarks
Based on expiry date
Material
glass: clear
paper: white; blue; black
cardboard: white; blue
plastic: blue
metal: silver
rubber: pink
Inscriptions
(a) Front: "5 ML. Bio. 1568 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1973-74 season. // Stock 4-1568-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 1000 CCA units per human dose (0.5 // ml.) in the recommended ratio of 700 CCA units of the A // influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injections // of 0.5 ml. each, given at least two months apart. See // package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propogated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1568 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] Feb. 1, 1975 // 903033B [stamped]"; (b) front: "C // 5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains no less than 1000 CCA units per human dose // (0.5 ml.) in the recommended ratio of 700 CCA units of the A influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – Two // intramuscular injections of 0.5 // ml. each, given at least two months apart. See package // inssert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp Date and Lot [printed] // Feb. 1, 1975 // 903033B [stamped]"; bottom: "W // 83 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "C // FLUOGEN® // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 877800 C-PO // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from DESCRIPTION] // INDICATIONS // [text follows] // 121 877800 2 C - PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from INDICATIONS] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 121 877800 3 C-PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 877800 //Parke, Davis & Co. // Detroit, Mi 48232 USA C-PD // A // Issued Aprile 1973 [French translation appears alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Condition Remarks
Box somewhat dirty, dented; no apparent problems wtih vial or leaflet
Copy Type
Original
Reference Types
Other
JPG
Reference Comments
See also 000.001.282; CD #8
Images
Less detail
Dates
1974
circa 1974
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001282 a-c
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
  1 image  
Accession Number
000001282 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1974
circa 1974
Date Remarks
Based on expiry date
Material
glass: clear
paper: white; blue; black
cardboard: white; blue
plastic: blue
metal: silver
rubber: pink
Inscriptions
(a) Front: "5 ML. Bio. 1568 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1973-74 season. // Stock 4-1568-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 1000 CCA units per human dose (0.5 // ml.) in the recommended ratio of 700 CCA units of the A // influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injections // of 0.5 ml. each, given at least two months apart. See // package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propogated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1568 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] Nov. 15, 1974 // 903028C [stamped]"; (b) front: "C // 5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains no less than 1000 CCA units per human dose // (0.5 ml.) in the recommended ratio of 700 CCA units of the A influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – Two // intramuscular injections of 0.5 // ml. each, given at least two months apart. See package // inssert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp Date and Lot [printed] // Nov. 15, 1974 // 903028C [stamped]"; bottom: "W // 91 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "C // FLUOGEN® // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 877800 C-PO // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from DESCRIPTION] // INDICATIONS // [text follows] // 121 877800 2 C - PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from INDICATIONS] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 121 877800 3 C-PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 877800 //Parke, Davis & Co. // Detroit, Mi 48232 USA C-PD // A // Issued Aprile 1973 [French translation appears alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Condition Remarks
Box somewhat dirty, dented; no apparent problems wtih vial or leaflet
Copy Type
Original
Reference Types
Other
JPG
Reference Comments
See also 000.001.281; CD #8
Images
Less detail

Influenza Virus Vaccine

https://mhc.andornot.com/en/permalink/artifact4076
Dates
1969
circa 1969
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001283 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over vial neck and lip; vial is in a cardboard box (a) with a paper leaflet (c); there is a square white sticker on left side of box
  1 image  
Accession Number
000001283 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over vial neck and lip; vial is in a cardboard box (a) with a paper leaflet (c); there is a square white sticker on left side of box
Number Of Parts
3
Part Names
a - box - Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Length 5.2 cm x Diam. 2.6 cm
c - leaflet (unfolded) - Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis.
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1969
circa 1969
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; red; blue; black
cardboard: white; blue; red; black
rubber: pink
glass: clear
Inscriptions
(a) Front: "10 CC. Bio. 844 // INFLUENZA VIRUS VACCINE, // BIVALENT // C // Contains: A2 //Japan/170/62, A2 // Taiwan/1/64 // and B/Massachusetts/3/66 strains. // BIVALENT // Stock 4-844-1-70 // PARKE-DAVIS"; bottom: "Standardized according to the U.S. Public Health // Service requirements for the 1968-69 season. // Contains 0.01% thymersal (mercury derivative). // Store at temperature between 2° and 8° C. // (35.6° and 46.4° F.). // FREEZING DESTROYS POTENCY"; back: "Prepared from the refined extra-embryonic fluid of // the chick embryo, killed by ultraviolet irradiation // and formalin, and absorbed on aluminum phosphate. // U.S. Licence No. 1 // Canadian Licence no. 1"; top: "SHAKE WELL BEFORE USING // USUAL ADULT DOSE – Two intramuscular injec- // tions of 1 cc. each, given at least two months // apart. See package insert. // Parke, Davis & Company // Detroit, Michigan, U.S.A. 48232"; right side: "10 CC. Bio. 844 // INFLUENZA // VIRUS VACCINE, // BIVALENT // Parke, Davis & Co. // Expiration Date and Lot // NOV 15, 1969 // 985259B"; left side: "10 CC. Bio. 844 // INFLUENZA // VIRUS VACCINE, // B1 [illeg.] // Pa [illeg.] Co. // S [illeg.]"; (b) front: "C 10 CC. Bio. 844 // INFLUENZA VIRUS VACCINE, // BIVALENT // Contains: A2 // Japan/170/62, A2 /Taiwan/64 // and B/Massachusetts/3/66 strains. // Standardized according to the U.S. Public // Health Service requirements for the // 1968-69 season. // BIVALENT // PARKE, DAVIS & CO. DETROIT, Mich., U.S.A."; back: "USUAL ADULT DOSE // Two intramuscular in- // jections of 1 cc. each, // given at least two months // apart. See package // insert. // SHAKE WELL // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Expiration date and Lot // Nov. 15, 1969 // 985259B "; bottom: "NT I // K // 10 // U.S.A."; (c) "C // INFLUENZA VIRUS VACCINE // BIVALENT POLYVALENT // PARKE-DAVIS // Beginning with the 1967-68 season, Influenza Virus // Vaccine is supplied in two formulas: // [text follows] // INDICATIONS // [text follows] // HB // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 2 // HB // [text continues from Adverse Reactions] // ADMINISTRATION AND DOSAGE // [text follows] // 3 // HB // [text continues from Administration] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // PARKE, DAVIS [logo, see sketch on accession sheet] & COMPANY // 121 856750 // K - 97 - A DETROIT, MICHIGAN, U.S.A. HB // Issued Mar. 1968 [French translation accompanies English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Temporary Location
On loan to Museum of Health Care Education Department for Seniors’ Learning Program 22 Aug 2016.
Condition Remarks
Box somewhat yellowed, dented, dirty; leaflet mottled with a yellow stain throughout; no apparent problems with vial
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail

Influenza Virus Vaccine vial

https://mhc.andornot.com/en/permalink/artifact4077
Dates
1981
circa 1981
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001284 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (…
  1 image  
Accession Number
000001284 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1981
circa 1981
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; blue; black
cardboard: white; blue; black
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "DIN 248991 Stock 4-4079-63-70 // INFLUENZA VIRUS VACCINE, // TRIVALENT, TYPES A AND B // FLUOGEN® Subvirion Vaccine // Dose – Persons 27 years and older, a single injection of 0.5 ml; // persons 3 years through 26 years, 2 injections of 0.5 ml, 4 or // more weeks apart; persons 6 months through 35 months, 2 // injections of 0.25 ml, 4 or more weeks apart. Inject // intramuscularly. See package insert. // 5 ml PARKE-DAVIS"; bottom: "Standardized according to 1979-80 NACI and US PHS requirements. // Contains no less than 21 micrograms of HA antigen content per // 0.5 ml dose in the recommended ratio of 7µg of HA of the A // influenza virus component representative of A/Brazil/78 (H1N1), 7 // µg of HA of the A influenza virus component representative of // A/Texas/1/77 (H3N2), and 7µg of HA of the B influenza virus component representative of B/Hong Kong/5/72. The vaccine is of chick embryo origin. // Polysorbate 80, USP, added during manufacture. // Preservative: 0.01% thimer- // osal (mercury derivative). //Store at temperature between // 2° and 8° C (36° and 46° F). // Freezing destroys potency. // Exp date and lot [printed] // FEB. 5, 1981 // YH601 [stamped]"; back: front repeated in French; top: bottom repeated in French up to and including "Freezing destroys potency"] // Permis US n°1 Permis can. n°1 // Parke, Davis & Co/Detroit, Mi 48232 USA"; right side: "5 ml // FLUOGEN // U.S. Lic. No. 1 Can. Lic. No. 1 // PARKE-DAVIS"; left side: "5 ml // FLUOGEN // Stock 4-4079-63-70 // PARKE-DAVIS // Printed in USA // 120 // 457217"; (b) front: "DIN 248991 C // INFLUENZA VIRUS VACCINE, TRIVALENT // TYPES A AND B FLUOGEN® Subvirion // Vaccine // [contents as listed on box front] // The vaccine is of chick embryo origin. // 5 ml PARKE-DAVIS"; back: "LOT YH607 [stamped] // Dose – See package insert. // Standardized according to // the NACI and the US PHS // requirements for the // 1979-80 season. // Stock 4-4079-63-70 // U.S. Lic. No. 1 Can Lic. No. 1 [printed] // EXP FEB. 5, 1981 [stamped] // Parke, Davis & Co // Detroit, Mi 48232 USA // 02 4079 70 1 [printed]"; bottom: "W // 79 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "FLUOGEN® // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // Subvirion Vaccine/Immunizing Antigen, Ether Extracted // DESCRIPTION // [text follows] // ACTION // [text follows] // PARKE-DAVIS // 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Action] // INDICATIONS // 2 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // WARNING // [text follows] // PRECAUTIONS // [text follows] // USAGE IN PREGNANCY // [text follows] // ADVERSE REACTIONS // 3 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Adverse Reactions] // DOSAGE AND ADMINISTRATION // [text follows] // STORAGE // [text follows] // PACKAGE INFORMATION // [text follows] // Unpublished data available upon request. // Issued June 1979 // Parke, Davis & Co., Detroit, Mi 48232 USA 121 887150/C-KF // [French translation accompanies English text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box somewhat yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail
Dates
1975
circa 1975
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001285 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper …
  1 image  
Accession Number
000001285 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Vaccination
Influenza
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1975
circa 1975
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; red; black
cardboard: white; blue; red
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "5 ML. Bio. 1600 // FLUOGEN®-B // Standardized according to the U.S. Public // Health Service requirements for the 1973-74 season. // Stock 4-1600-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // PARKE, DAVIS & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1600 // INFLUENZA VIRUS VACCINE, MONVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 500 CCA units per human dose // (0.5 ml.) of a type B influenza virus strain representative of // B/Hong Kong /5/72. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – One intramuscular injection of // 0.5 ml. See package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propagated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1600 // FLUOGEN®-B // PARKE-DAVIS [printed] // Exp. Date and Lot // Feb. [stamped] 75 [handwritten] // 903619A [stamped] // 120 // 455817 [printed]"; (b) front: "5 ML. Bio. 1600 // INFLUENZA VIRUS VACCINE MONOVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN®-B // Contains no less than 500 CCA units per human // dose (0.5 ml.) of a type B influenza virus strain // representative of B/Hong Kong/5/72. // Parke, Davis & Co/Detroit, Mi 48232 USA C [printed] // USUAL ADULT DOSE – One // intramuscular injection of 0.5 // ml. See package insert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp. Date and Lot [printed] // Feb. 5, 1975 // 903619A [stamped]"; bottom: "W // 88 [embossed]"; top: "FLIP // OFF [embossed]"; (c) FLUOGEN®-B // INFLUENZA VIRUS VACCINE, MONOVALENT // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 878100 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from Description] // INDICATIONS // [text follows] // 121 878100 2 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // 121 878100 2 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // ADVERSE REACTIONS // [text follows] // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 878100 // PARKE, DAVIS & Co // Detroit Mi 48232 USA // A // Issued June 1973 // C-PF // [French translation accompanies English, alongside text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail

22 records – page 1 of 3.